Antagonism of limbic and extrapyramidal actions of intracerebrally injected dopamine by ergolines with partial D2 agonist activity in the rat

Brain Research

Volumn 592, Issue 1-2, 1992, Pages 348-352

  Campbell, A ^a   Baldessarini, R J ^a   Yeghiayan, S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antipsychotic; Dopamine; Ergoline; Extrapyramidal; Intracranial injection; Limbic; Stereotaxic

Indexed keywords

BROMOCRIPTINE; DOPAMINE; DOPAMINE 2 RECEPTOR; ERGOLINE; ERGOLINE DERIVATIVE; N (2 CHLORO 6 METHYLERGOLIN 8ALPHA YL)PIVALAMIDE; N (2,6 DIMETHYLERGOLIN 8ALPHA YL)PIVALAMIDE; PARGYLINE; SDZ 212327; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EXTRAPYRAMIDAL SYSTEM; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BEHAVIOR, ANIMAL; BRAIN; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; ERGOLINES; EXTRAPYRAMIDAL TRACTS; INJECTIONS; INJECTIONS, INTRAPERITONEAL; LIMBIC SYSTEM; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026669741     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(92)91696-C     Document Type: Article

References (19)

1. Bromocriptine antagonizes behavioral effects of cocaine in the rat
2. R(−) and S(+) stereoisomers of 11-hydroxy-N-n-propylnoraporphine: central dopaminerigc behavioral activity in the rat
3. S(+)-methylenedioxy-N-n-propylnoraporphine: an orally active inhibitror of dopamine selective for rat limbic system
4. S(+)-aporphines: selective inhibition of excitatory effects of dopamine injected into rat limbic system
5. Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)-N-n-propylnoraporphines
6. Selective antidopaminergic effects of S(+)-N-n-propylnoraporphines in limbic vs. extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents
7. Non-classical neuroleptic-like properties of partial dopamine agonists
8. Pharmacological properties of SDZ-208-912: a potential high potency, non-classical neuroleptic
9. Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ-208-911 and SDZ-208-912
10. Partial DA-agonists as potential anti-schizophrenic agents
11. Dopamine receptor subtypes: their involvement in motor regulation
12. Simultaneous analysis of families of sigmoid curves: application to bioassay, radioligand assay and physiological dose-response curves
13. Dopaminephilic properties of ergot alkaloids
14. 2 dopamine receptor agonists
15. Structure activity relationship and therapeutic uses of dopaminergic ergots
16. Dopaminergic ergots